A detailed history of Clear Harbor Asset Management, LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 19,500 shares of QURE stock, worth $111,150. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,500
Previous 48,000 59.38%
Holding current value
$111,150
Previous $215,000 55.35%
% of portfolio
0.01%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$3.78 - $10.12 $107,730 - $288,420
-28,500 Reduced 59.38%
19,500 $96,000
Q2 2024

Jul 17, 2024

BUY
$4.39 - $5.43 $54,874 - $67,875
12,500 Added 35.21%
48,000 $215,000
Q1 2024

May 10, 2024

BUY
$4.82 - $6.93 $108,932 - $156,618
22,600 Added 175.19%
35,500 $184,000
Q4 2023

Jan 18, 2024

SELL
$5.63 - $8.27 $59,002 - $86,669
-10,480 Reduced 44.82%
12,900 $87,000
Q3 2023

Oct 26, 2023

BUY
$6.71 - $11.83 $156,879 - $276,585
23,380 New
23,380 $156,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $266M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Clear Harbor Asset Management, LLC Portfolio

Follow Clear Harbor Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.